title: Can treatment with the monoclonal antibody BMA031 induce cytokine release?
authors.affiliation: Institute of Immunology, University of Vienna, Austria.
authors.forename: G J
authors.initials: GJ
authors.lastname: Zlabinger
authors.forename: E
authors.initials: E
authors.lastname: Pohanka
authors.forename: K M
authors.initials: KM
authors.lastname: Stuhlmeier
authors.forename: R
authors.initials: R
authors.lastname: Eher
authors.forename: S
authors.initials: S
authors.lastname: Schmaldienst
authors.forename: B
authors.initials: B
authors.lastname: Watschinger
authors.forename: G
authors.initials: G
authors.lastname: Steiner
authors.forename: J
authors.initials: J
authors.lastname: Kovarik
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006084:Graft Rejection; D006801:Humans; D007371:Interferon-gamma / Q000097:blood*; D016030:Kidney Transplantation / Q000276:immunology*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma